Identification of Potential Therapeutic Targets and Drugs for Depression: A Genome-Wide Druggable Mendelian Randomization and Molecular Docking Study.
34 potential druggable targets for depression were found, with SNRK, MANF, and P4HTM showing consistent importance across tissues and quercetagetin and myricetin emerged as promising candidates for depression therapy.